University of Würzburg, Institute of Clinical Epidemiology and Biometry, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany.
Eur J Heart Fail. 2014 Oct;16(10):1133-41. doi: 10.1002/ejhf.150. Epub 2014 Aug 20.
Depression is common in heart failure (HF) and associated with adverse outcomes. Randomized comparisons of the effectiveness of HF care strategies by patients' mood are scarce. We therefore investigated in a randomized trial a structured collaborative disease management programme (HeartNetCare-HF™; HNC) recording mortality, morbidity, and symptoms in patients enrolled after hospitalization for decompensated systolic HF according to their responses to the 9-item Patient Health Questionnaire (PHQ-9) during an observation period of 180 days.
Subjects scoring <12/≥12 were categorized as non-depressed/depressed, and those ignoring the questionnaire as PHQ-deniers. Amongst 715 participants (69 ± 12 years, 29% female), 141 (20%) were depressed, 466 (65%) non-depressed, and 108 (15%) PHQ-deniers. The composite endpoint of mortality and re-hospitalization was neutral overall and in all subgroups. However, HNC reduced mortality risk in both depressed and non-depressed patients [adjusted hazard ratios (HRs) 0.12, 95% confidence interval (CI) 0.03-0.56, P = 0.006, and 0.49, 95% CI 0.25-0.93, P = 0.03, respectively], but not in PHQ-deniers (HR 1.74, 95% CI 0.77-3.96, P = 0.19; P = 0.006 for homogeneity of HRs). Average frequencies of patient contacts in the HNC arm were 12.8 ± 7.9 in non-depressed patients, 12.4 ± 7.1 in depressed patients, and 5.5 ± 7.2 in PHQ-deniers (P < 0.001).
Early after decompensation, HNC reduced mortality risk in non-depressed and even more in depressed subjects, but not in PHQ-deniers. This suggests that differential acceptability and chance of success of care strategies such as HNC might be predicted by appropriate assessment of patients' baseline characteristics including psychological disposition. These post-hoc results should be reassessed by prospective evaluation of HNC in larger HF populations.
抑郁症在心力衰竭(HF)中很常见,并且与不良结局相关。根据患者的情绪对 HF 护理策略的有效性进行随机比较的研究很少。因此,我们在一项随机试验中调查了根据他们在观察期 180 天内对 9 项患者健康问卷(PHQ-9)的反应,对因失代偿性收缩性 HF 住院后的患者进行记录死亡率、发病率和症状的结构化协作疾病管理计划(HeartNetCare-HF™;HNC)的有效性。方法和结果:得分<12/≥12 的受试者被归类为非抑郁/抑郁,忽略问卷的受试者被归类为 PHQ-否认者。在 715 名参与者中(69±12 岁,29%为女性),141 名(20%)为抑郁,466 名(65%)为非抑郁,108 名(15%)为 PHQ-否认者。总体和所有亚组的死亡率和再入院的复合终点均为中性。然而,HNC 降低了抑郁和非抑郁患者的死亡率风险[调整后的危险比(HR)分别为 0.12、95%置信区间(CI)0.03-0.56,P=0.006 和 0.49、95%CI 0.25-0.93,P=0.03],但 PHQ-否认者的风险没有降低(HR 1.74、95%CI 0.77-3.96,P=0.19;P=0.006 用于 HR 同质性)。HNC 臂中患者接触的平均频率为非抑郁患者 12.8±7.9,抑郁患者 12.4±7.1,PHQ-否认者 5.5±7.2(P<0.001)。结论:在失代偿后早期,HNC 降低了非抑郁患者的死亡率风险,甚至降低了抑郁患者的死亡率风险,但 PHQ-否认者的风险没有降低。这表明,包括心理倾向在内的患者基线特征的适当评估可以预测诸如 HNC 等护理策略的可接受性和成功机会的差异。这些事后结果应通过对更大的 HF 人群进行前瞻性评估来重新评估 HNC。